Biliary sepsis. Reviewing treatment options.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 3086069)

Published in Drugs on May 01, 1986

Authors

R Munro, T C Sorrell

Articles by these authors

Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 3.45

Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med J Aust (2001) 3.36

Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol (2001) 3.02

Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59

Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis (1999) 2.17

Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev (2006) 2.13

Infective endocarditis due to nontoxigenic Corynebacterium diphtheriae: report of seven cases and review. Clin Infect Dis (1993) 2.00

Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet (1971) 1.93

Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis (1997) 1.72

A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother (1985) 1.64

Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol (1986) 1.60

Campylobacter jejuni: incidence in processed broilers and biotype distribution in human and broiler isolates. Appl Environ Microbiol (1982) 1.56

Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun (1997) 1.45

Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea. Med J Aust (1992) 1.44

An unusual manifestation of malignant catarrhal fever in a yearling bull. Vet Rec (1994) 1.40

Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol (1975) 1.40

Campylobacter jejuni in broilers: the role of vertical transmission. J Hyg (Lond) (1986) 1.38

Cryptococcosis: clinical and biological aspects. Med Mycol (2000) 1.35

Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. Br Med J (Clin Res Ed) (1983) 1.31

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect (2009) 1.28

Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect (2009) 1.24

Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts. Trans R Soc Trop Med Hyg (1998) 1.23

Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transpl Infect Dis (2009) 1.22

Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in South Western Sydney. Pathology (2001) 1.22

Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J (2000) 1.19

Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology (1983) 1.18

Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis (1997) 1.17

Characterization of Cryptococcus neoformans by random DNA amplification. Lett Appl Microbiol (1996) 1.15

Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Med Mycol (2003) 1.14

Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis (1992) 1.13

Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol (1997) 1.12

HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology (1992) 1.12

Haemostasis in fish--an evolutionary perspective. Thromb Haemost (1997) 1.11

Lyme disease: a search for a causative agent in ticks in south-eastern Australia. Epidemiol Infect (1994) 1.10

Horizontal transmission of Campylobacter jejuni amongst broiler chicks: experimental studies. Epidemiol Infect (1990) 1.10

Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis (1999) 1.10

Rapid diagnosis of intravascular catheter-related sepsis. Arch Intern Med (1987) 1.09

Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol (1997) 1.08

Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors. Magn Reson Med (1999) 1.08

In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1983) 1.06

Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol Infect (2000) 1.06

Aeromonas septicemia: relationship of species and clinical features. Pathology (1989) 1.05

Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen. J Immunol (1978) 1.05

Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol (1999) 1.04

Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread. Clin Diagn Lab Immunol (2000) 1.04

Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect (2011) 1.02

Identification by random amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var. neoformans in patients with AIDS or other immunosuppressive conditions. J Infect Dis (1996) 1.02

Cellulitis due to Pseudomonas putrefaciens: possible production of exotoxins. Rev Infect Dis (1991) 1.02

Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology (2001) 1.02

A cluster of meningococcal disease in western Sydney, Australia initially associated with a nightclub. Epidemiol Infect (1998) 1.01

Systemic sepsis and intravenous devices. A prospective survey. Med J Aust (1984) 1.01

Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis (2007) 1.01

In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis. Eur J Clin Microbiol (1982) 0.97

Sensitivity of Gardnerella vaginalis to metabolites of metronidazole and tinidazole. Lancet (1982) 0.96

Epidemiology of meningococcal disease in Australia. J Paediatr Child Health (2001) 0.95

hUBC9 associates with MEKK1 and type I TNF-alpha receptor and stimulates NFkappaB activity. FEBS Lett (1998) 0.95

Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun (1992) 0.95

PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol (2001) 0.94

A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol (1992) 0.94

The Bellagio Task Force report on transplantation, bodily integrity, and the International Traffic in Organs. Transplant Proc (1997) 0.93

Experimental colonization of broiler chicks with Campylobacter jejuni. Epidemiol Infect (1988) 0.93

Psoroptic mange in goats in Fiji. Trop Anim Health Prod (1980) 0.93

Recommendations for the treatment of established fungal infections. Intern Med J (2008) 0.93

Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999. Pathology (2001) 0.92

Robust, routine haematology reference ranges for healthy adults. Int J Lab Hematol (2007) 0.92

Is the antimicrobial removal device a cost-effective addition to conventional blood cultures? J Clin Pathol (1984) 0.91

Partial sequence analysis of the actin gene and its potential for studying the phylogeny of Candida species and their teleomorphs. Int J Syst Evol Microbiol (2001) 0.91

A national survey of antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals. Med J Aust (1989) 0.91

Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008. J Hosp Infect (2010) 0.91

Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol (1992) 0.90

Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust (1997) 0.90

Ocular metastasis of bladder cancer. South Med J (1974) 0.90

A rapid slid coagglutination test-an alternative to the fluorescent antibody test for the identification of Neisseria gonorrhoeae. J Clin Pathol (1981) 0.90

Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Exp Cell Res (1998) 0.90

Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol (2009) 0.89

Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci (2009) 0.88

Pseudomonas putrefaciens bacteraemia in a peritoneal dialysis patient. Nephrol Dial Transplant (1991) 0.86

Detection and serogroup determination of Neisseria meningitidis in CSF by polymerase chain reaction (PCR). Pathology (2000) 0.86

Inhibition of platelet eicosanoid metabolism by the bacterial phenazine derivative pyocyanin. Ann N Y Acad Sci (1994) 0.86

Production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by human neutrophils is inhibited by Pseudomonas aeruginosa phenazine derivatives. Infect Immun (1991) 0.86

Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity: case report. Clin Infect Dis (1994) 0.85

Infection of vascular prostheses. Aust N Z J Surg (1991) 0.85

Relative changes in blood flow with functional electrical stimulation during exercise of the paralyzed lower limbs. Paraplegia (1995) 0.85

HomeChoice automated peritoneal dialysis machines: the impact of reuse of tubing and cassettes. Perit Dial Int (2000) 0.85

Real-time PCR detection and quantitation of Chlamydophila psittaci in human and avian specimens from a veterinary clinic cluster. Eur J Clin Microbiol Infect Dis (2008) 0.85

A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates. J Med Microbiol (2000) 0.85

Laboratory diagnosis of intravascular catheter associated sepsis. Eur J Clin Microbiol Infect Dis (1989) 0.85

The detection of Alcelaphine herpesvirus-1 DNA by in situ hybridization of tissues from rabbits affected with malignant catarrhal fever. J Comp Pathol (1992) 0.84

Lynxacarus on cats in Fiji. Aust Vet J (1979) 0.84

Regulatory roles for the homeodomain and C2H2 zinc finger regions of Cryptococcus neoformans Ste12alphap. Mol Microbiol (2004) 0.83

Histopathological findings in the lungs of Scottish red and roe deer. Vet Rec (1983) 0.83

M-6 endocarditis: report of an Australian case. Pathology (1993) 0.83

Chlamydiosis and abortion in a dairy herd. Vet Rec (1994) 0.82

Defining the spatial impacts of poultry farm ammonia emissions on species composition of adjacent woodland groundflora using Ellenberg Nitrogen Index, nitrous oxide and nitric oxide emissions and foliar nitrogen as marker variables. Environ Pollut (2002) 0.81

Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J (2014) 0.81